留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

中国肾脏移植受者消化系统并发症临床诊疗指南

中华医学会器官移植学分会, 杨猛, 秦文瀚, 等. 中国肾脏移植受者消化系统并发症临床诊疗指南[J]. 器官移植. doi: 10.3969/j.issn.1674-7445.2024126
引用本文: 中华医学会器官移植学分会, 杨猛, 秦文瀚, 等. 中国肾脏移植受者消化系统并发症临床诊疗指南[J]. 器官移植. doi: 10.3969/j.issn.1674-7445.2024126
Branch of Organ Transplantation of Chinese Medical Association, , , et al. Clinical diagnosis and treatment guidelines for digestive system complications in kidney transplant recipients in China[J]. ORGAN TRANSPLANTATION. doi: 10.3969/j.issn.1674-7445.2024126
Citation: Branch of Organ Transplantation of Chinese Medical Association, , , et al. Clinical diagnosis and treatment guidelines for digestive system complications in kidney transplant recipients in China[J]. ORGAN TRANSPLANTATION. doi: 10.3969/j.issn.1674-7445.2024126

中国肾脏移植受者消化系统并发症临床诊疗指南

doi: 10.3969/j.issn.1674-7445.2024126
基金项目: 全军临床重点专科建设(41561Z23785)
详细信息
    通讯作者:

    赵洪雯,Email:zhaohongwen@tmmu.edu.cn

  • 中图分类号: R617, R57

Clinical diagnosis and treatment guidelines for digestive system complications in kidney transplant recipients in China

More Information
  • 摘要: 肾脏移植受者消化系统并发症的诊治关系患者长期存活及生存质量,需要高度关注,为进一步规范其诊断与治疗,中华医学会器官移植学分会发起制订《中国肾脏移植受者消化系统并发症临床诊疗指南》,并组织器官移植学和相关学科专家,依据现有临床研究、系统评价、病例研究、专家共识和现有指南等,总结近年来国内外在肾脏移植受者消化系统并发症诊治方面的新进展,经过多次研讨达成一致意见后撰写成文。全文围绕11个临床问题,形成16条推荐意见,使用2009版牛津大学循证医学中心的证据分级与推荐强度标准对每个临床问题的证据质量和推荐强度进行分级,以期为肾脏移植受者消化系统并发症的诊疗提供参考,全面提升临床医师对消化系统并发症的管理能力,造福移植受者。

     

  • 表  1  2009版OCEBM证据分级与推荐意见强度分级标准

    Table  1.   Level of evidence and recommended grades of OCEBM in 2009

    推荐强度 证据等级 描述
    A 1a 多项随机对照试验的系统评价
    1b 结果可信区间小的随机对照试验
    1c 显示“全或无效应”的任何证据
    B 2a 队列研究的系统评价
    2b 单个的队列研究(包括低质量的随机对照试验,如失访率>20%者)
    2c 基于患者结局的研究
    3a 病例对照研究的系统评价
    3b 单个病例对照研究
    C 4 病例系列报告、低质量队列研究和低质量病例对照研究
    D 5 专家意见(即无临床研究支持仅依据基础研究或临床经验的推测)
    下载: 导出CSV
  • [1] BUNNAPRADIST S, NERI L, WONG W, et al. Incidence and risk factors for diarrhea following kidney transplantation and association with graft loss and mortality[J]. Am J Kidney Dis, 2008, 51(3): 478-486. DOI: 10.1053/j.ajkd.2007.11.013.
    [2] ZAIS IE, SIROTTI A, IESARI S, et al. Human cytomegalovirus-related gastrointestinal disease after kidney transplantation: a systematic review[J]. Clin Transplant, 2024, 38(1): e15218. DOI: 10.1111/ctr.15218.
    [3] DEBORSKA-MATERKOWSKA D, SADOWSKA A, MATŁOSZ B, et al. Human herpes virus 6 infection in renal transplant recipient—case report[J]. Przegl Epidemiol, 2006, 60(1): 141-146.
    [4] PATIL AD, SAXENA NG, THAKARE SB, et al. Diarrhea after kidney transplantation: a study of risk factors and outcomes[J]. J Postgrad Med, 2023, 69(4): 205-214. DOI: 10.4103/jpgm.jpgm_601_22.
    [5] SHAH SA, TSAPEPAS DS, KUBIN CJ, et al. Risk factors associated with Clostridium difficile infection after kidney and pancreas transplantation[J]. Transpl Infect Dis, 2013, 15(5): 502-509. DOI: 10.1111/tid.12113.
    [6] DUMOND C, AULAGNON F, ETIENNE I, et al. Epidemiological and clinical study of microsporidiosis in French kidney transplant recipients from 2005 to 2019: TRANS-SPORE registry[J]. Transpl Infect Dis, 2021, 23(5): e13708. DOI: 10.1111/tid.13708.
    [7] GRAS J, ABDEL-NABEY M, DUPONT A, et al. Clinical characteristics, risk factors and outcome of severe Norovirus infection in kidney transplant patients: a case-control study[J]. BMC Infect Dis, 2021, 21(1): 351. DOI: 10.1186/s12879-021-06062-2.
    [8] AZEVEDO P, FREITAS C, AGUIAR P, et al. A case series of de novo inflammatory bowel disease after kidney transplantation[J]. Transplant Proc, 2013, 45(3): 1084-1087. DOI: 10.1016/j.transproceed.2013.03.008.
    [9] KATO T, YAZAWA K, MADONO K, et al. Acute graft-versus-host-disease in kidney transplantation: case report and review of literature[J]. Transplant Proc, 2009, 41(9): 3949-3952. DOI: 10.1016/j.transproceed.2009.05.030.
    [10] KIM JM, KIM SJ, JOH JW, et al. Graft-versus-host disease after kidney transplantation[J]. J Korean Surg Soc, 2011, 80(Suppl 1): S36-S39. DOI: 10.4174/jkss.2011.80.Suppl1.S36.
    [11] ALMEIDA CC, SILVEIRA MR, DE ARAÚJO VE, et al. Safety of immunosuppressive drugs used as maintenance therapy in kidney transplantation: a systematic review and meta-analysis[J]. Pharmaceuticals (Basel), 2013, 6(10): 1170-1194. DOI: 10.3390/ph6101170.
    [12] 孙雯, 郭宏波, 解泽林, 等. 肾移植患者术后腹泻的相关因素分析[J]. 北京大学学报(医学版), 2013, 45(5): 779-781. DOI: 10.3969/j.issn.1671-167X.2013.05.025.

    SUN W, GUO HB, XIE ZL, et al. Association factors analysis of diarrhea in patients receiving kidney transplantation[J]. J Peking Univ (Health Sci), 2013, 45(5): 779-781. DOI: 10.3969/j.issn.1671-167X.2013.05.025.
    [13] WEBSTER AC, WOODROFFE RC, TAYLOR RS, et al. Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial data[J]. BMJ, 2005, 331(7520): 810. DOI: 10.1136/bmj.38569.471007.AE.
    [14] MALINOWSKI M, MARTUS P, LOCK J F, et al. Systemic influence of immunosuppressive drugs on small and large bowel transport and barrier function[J]. Transpl Int, 2011, 24(2): 184-193. DOI: 10.1111/j.1432-2277.2010.01167.x.
    [15] VASQUEZ E M. Sirolimus: a new agent for prevention of renal allograft rejection[J]. Am J Health Syst Pharm, 2000, 57(5): 437-451. DOI: 10.1093/ajhp/57.5.437.
    [16] SOLLINGER HW. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. U. S. Renal Transplant Mycophenolate Mofetil Study Group[J]. Transplantation, 1995, 60(3): 225-232. DOI: 10.1097/00007890-199508000-00003.
    [17] ZIEGLER TR, FERNÁNDEZ-ESTÍVARIZ C, GU LH, et al. Severe villus atrophy and chronic malabsorption induced by azathioprine[J]. Gastroenterology, 2003, 124(7): 1950-1957. DOI: 10.1016/S0016-5085(03)00405-0.
    [18] MAES B, HADAYA K, DE MOOR B, et al. Severe diarrhea in renal transplant patients: results of the DIDACT study[J]. Am J Transplant, 2006, 6(6): 1466-1472. DOI: 10.1111/j.1600-6143.2006.01320.x.
    [19] CARENA AA, BOUGHEN S, GAGLIARDI MI, et al. Acute diarrhea after kidney or kidney-pancreas transplantation[J]. Medicina (B Aires), 2015, 75(1): 29-36.
    [20] SHI Y, LIU H, CHEN XG, et al. Comparison of mizoribine and mycophenolate mofetil with a tacrolimus-based immunosuppressive regimen in living-donor kidney transplantation recipients: a retrospective study in China[J]. Transplant Proc, 2017, 49(1): 26-31. DOI: 10.1016/j.transproceed.2016.10.018.
    [21] SUGITANI A, KITADA H, OTA M, et al. Revival of effective and safe high-dose mizoribine for the kidney transplantation[J]. Clin Transplant, 2006, 20(5): 590-595. DOI: 10.1111/j.1399-0012.2006.00522.x.
    [22] RANGEL EB, MELARAGNO CS, SÁ JR, et al. Mycophenolate mofetil versus enteric-coated mycophenolate sodium after simultaneous pancreas-kidney transplantation[J]. Transplant Proc, 2009, 41(10): 4265-4269. DOI: 10.1016/j.transproceed.2009.09.060.
    [23] SOOD MM, GARG AX, BOTA SE, et al. Risk of major hemorrhage after kidney transplantation[J]. Am J Nephrol, 2015, 41(1): 73-80. DOI: 10.1159/000371902.
    [24] SOOD MM, BOTA SE, MCARTHURE, et al. The three-year incidence of major hemorrhage among older adults initiating chronic dialysis[J]. Can J Kidney Health Dis, 2014, 1: 21. DOI: 10.1186/s40697-014-0021-x.
    [25] COLLINS MG, TEO E, COLE SR, et al. Screening for colorectal cancer and advanced colorectal neoplasia in kidney transplant recipients: cross sectional prevalence and diagnostic accuracy study of faecal immunochemical testing for haemoglobin and colonoscopy[J]. BMJ, 2012, 345: e4657. DOI: 10.1136/bmj.e4657.
    [26] RENCUZOGULLARI A, BINBOGA S, AYTAC E, et al. Incidence, management, and risk factors for lower gastrointestinal bleeding in renal transplant recipients[J]. Transplant Proc, 2017, 49(3): 501-504. DOI: 10.1016/j.transproceed.2017.02.001.
    [27] WANG R, WANG Q. Comparison of risk scoring systems for upper gastrointestinal bleeding in patients after renal transplantation: a retrospective observational study in Hunan, China[J]. BMC Gastroenterol, 2022, 22(1): 353. DOI: 10.1186/s12876-022-02426-3.
    [28] PASCUAL J, GALEANO C, ROYUELA A, et al. A systematic review on steroid withdrawal between 3 and 6 months after kidney transplantation[J]. Transplantation, 2010, 90(4): 343-349. DOI: 10.1097/TP.0b013e3181e 58912.
    [29] ÇıNAR F, BULBULOGLU S. The effect of adherence to immunosuppressant therapy on gastrointestinal complications after liver transplantation[J]. Transpl Immunol, 2022, 71: 101554. DOI: 10.1016/j.trim.2022.101554.
    [30] 中华医学会消化内镜学分会结直肠学组, 中国医师协会消化医师分会结直肠学组, 国家消化系统疾病临床医学研究中心. 下消化道出血诊治指南(2020)[J]. 中华消化内镜杂志, 2020, 37(10): 685-695. DOI: 10.3760/cma.j.cn321463-20200618-00544.

    Colorectal Group of Branch of Digestive Endoscopy of Chinese Medical Association, Colorectal Group of Branch of Digestive Physicians of Chinese Medical Doctor Association, National Clinical Medical Research Center for Digestive System Diseases. Guideline for the diagnosis and treatment of lower gastrointestinal bleeding (2020)[J]. Chin J Dig Endosc, 2020, 37(10): 685-695. DOI: 10.3760/cma.j.cn321463-20200618-00544.
    [31] 中国医师协会急诊医师分会, 中华医学会急诊医学分会, 全军急救医学专业委员会, 等. 急性上消化道出血急诊诊治流程专家共识(2020版)[J]. 中华急诊医学杂志, 2021, 30(1): 15-24. DOI: 10.3760/cma.j.issn.1671-0282.2021.01.006.

    Branch of Emergency Physicians of Chinese Medical Doctor Association, Branch of Emergency Medicine of Chinese Medical Association, Military Emergency Medicine Professional Committee, et al. Expert consensus of emergency diagnosis and treatment of acute upper gastrointestinal hemorrhage[J]. Chin J Emerg Med, 2021, 30(1): 15-24. DOI: 10.3760/cma.j.issn.1671-0282.2021.01.006.
    [32] MULLADY DK, WANG AY, WASCHKE KA. AGA clinical practice update on endoscopic therapies for non-variceal upper gastrointestinal bleeding: expert review[J]. Gastroenterology, 2020, 159(3): 1120-1128. DOI: 10.1053/j.gastro.2020.05.095.
    [33] NELMS DW, PELAEZ CA. The acute upper gastrointestinal bleed[J]. Surg Clin North Am, 2018, 98(5): 1047-1057. DOI: 10.1016/j.suc.2018.05.004.
    [34] 周晓丽, 地里夏提·白克力, 尹东锋. 文献报道的替加环素诱发肾移植患者急性胰腺炎11例分析[J]. 药物流行病学杂志, 2022, 31(7): 492-496. DOI: 10.19960/j.cnki.issn1005-0698.2022.07.011.

    ZHOU XL, DILIXIATI·BKL, YIN DF. Literature analysis of 11 cases of tigecycline-induced acute pancreatitis in renal transplant patients[J]. Chin J Pharmacoepidemiol, 2022, 31(7): 492-496. DOI: 10.19960/j.cnki.issn1005-0698.2022.07.011.
    [35] 徐刚, 徐萍, 周艳钢, 等. 替加环素致肾移植术后急性胰腺炎3例分析[J]. 中南药学, 2021, 19(6): 1265-1268. DOI: 10.7539/j.issn.1672-2981.2021.06.044.

    XU G, XU P, ZHOU YG, et al. Tigecycline-induced acute pancreatitis in renal transplant patients: a report of 3 cases[J]. Cent South Pharm, 2021, 19(6): 1265-1268. DOI: 10.7539/j.issn.1672-2981.2021.06.044.
    [36] 刘东华, 邢晓敏, 杨雪, 等. 替加环素致肾移植术后患者急性胰腺炎[J]. 药物不良反应杂志, 2022, 8(3): 155-157. DOI: 10.3760/cma.j.cn114015-20210513-00551.

    LIU DH, XING XM, YANG X, et al. Acute pancreatitis induced by tigecycline in a patient after renal transplantation[J]. Adverse Drug React J, 2022, 8(3): 155-157. DOI: 10.3760/cma.j.cn114015-20210513-00551.
    [37] 李广萍, 吴江涛, 王琦, 等. 他克莫司致肾移植术后患者急性胰腺炎[J]. 药物不良反应杂志, 2022, 8(4): 213-215. DOI: 10.3760/cma.j.cn114015-20210510-00548.

    LI GP, WU JT, WANG Q, et al. Acute pancreatitis induced by tacrolimus in a patient after kidney transplantation[J]. Adverse Drug React J, 2022, 8(4): 213-215. DOI: 10.3760/cma.j.cn114015-20210510-00548.
    [38] 李伟杰, 丁玉峰. 肾移植术后给予替加环素致急性胰腺炎2例[J]. 医药导报, 2019, 38(10): 1367-1369. DOI: 10.3870/j.issn.1004-0781.2019.10.029.

    LI WJ, DING YF. Two cases of acute pancreatitis caused by tigecycline after renal transplantation[J]. Her Med, 2019, 38(10): 1367-1369. DOI: 10.3870/j.issn.1004-0781.2019.10.029.
    [39] XU J, XU L, WEI X, et al. A case report: acute pancreatitis associated with tacrolimus in kidney transplantation[J]. BMC Nephrol, 2019, 20(1): 209. DOI: 10.1186/s12882-019-1395-x.
    [40] ADANI GL, BACCARANI U, VIALE P, et al. Acute pancreatitis after kidney transplantation[J]. Am J Gastroenterol, 2005, 100(7): 1620. DOI: 10.1111/j.1572-0241.2005.50006_1.x.
    [41] Working Group IAP/APA Acute Pancreatitis Guidelines. IAP/APA evidence-based guidelines for the management of acute pancreatitis[J]. Pancreatology, 2013, 13(4 Suppl 2): e1-e15. DOI: 10.1016/j.pan.2013.07.063.
    [42] YANG CJ, CHEN J, PHILLIPS ARJ, et al. Predictors of severe and critical acute pancreatitis: a systematic review[J]. Dig Liver Dis, 2014, 46(5): 446-451. DOI: 10.1016/j.dld.2014.01.158.
    [43] MOUNZER R, LANGMEAD CJ, WU BU, et al. Comparison of existing clinical scoring systems to predict persistent organ failure in patients with acute pancreatitis[J]. Gastroenterology, 2012, 142(7): 1476-1482. DOI: 10.1053/j.gastro.2012.03.005.
    [44] 中华医学会外科学分会胰腺外科学组. 中国急性胰腺炎诊治指南(2021)[J]. 中国实用外科杂志, 2021, 41(7): 739-746. DOI: 10.19538/j.cjps.issn1005-2208.2021.07.03.

    Pancreatic Surgery Group of Branch of Surgery of Chinese Medical Association. Guidelines for diagnosis and treatment of acute pancreatitis in China(2021)[J]. Chin J Pract Surg, 2021, 41(7): 739-746. DOI: 10.19538/j.cjps.issn1005-2208.2021.07.03.
    [45] CROCKETT SD, WANI S, GARDNER TB, et al. American gastroenterological association institute guideline on initial management of acute pancreatitis[J]. Gastroenterology, 2018, 154(4): 1096-1101. DOI: 10.1053/j.gastro.2018.01.032.
    [46] MOGGIA E, KOTI R, BELGAUMKAR AP, et al. Pharmacological interventions for acute pancreatitis[J]. Cochrane Database Syst Rev, 2017, 4(4): CD011384. DOI: 10.1002/14651858.CD011384.pub2.
    [47] 罗桂金, 雷平光, 余洁梅, 等. 生长抑素联合质子泵抑制剂治疗重症胰腺炎患者的临床效果及对二胺氧化酶、D-乳糖的影响[J]. 广西医科大学学报, 2016, 33(3): 433-436. DOI: 10.16190/j.cnki.45-1211/r.2016.03.016.

    LUO GJ, LEI PG, YU JM, et al. The clinical effect of somatostatin and proton pump inhibitors in diamine oxidase, d-lactose of patients with severe pancreatitis[J]. J Guangxi Med Univ, 2016, 33(3): 433-436. DOI: 10.16190/j.cnki.45-1211/r.2016.03.016.
    [48] 陈美辰. 血液净化治疗在重症急性胰腺炎的应用进展[D]. 重庆: 重庆医科大学, 2022.
    [49] HAMMAD AY, DITILLO M, CASTANON L. Pancreatitis[J]. Surg Clin N Am, 2018, 98(5): 895-913. DOI: 10.1016/j.suc.2018.06.001.
    [50] SKIPWORTH JR, PEREIRA SP. Acute pancreatitis[J]. Curr Opin Crit Care, 2008, 14(2): 172-178. DOI: 10.1097/mcc.0b013e3282f6a3f9.
    [51] 文明波, 吴定国. 不同治疗时机的连续性肾脏替代治疗对重症急性胰腺炎疗效的影响[J]. 中华消化外科杂志, 2011, 10(2): 137-138. DOI: 10.3760/cma.j.issn.1673-9752.2011.02.018.

    WEN MB, WU DG. Effect of continuous renal replacement therapy with different treatment opportunities on severe acute pancreatitis[J]. Chin J Dig Surg, 2011, 10(2): 137-138. DOI: 10.3760/cma.j.issn.1673-9752.2011.02.018.
    [52] HANSRIVIJIT P, PUTHENPURA MM, THONGPRAYOON C, et al. Incidence and impacts of inflammatory bowel diseases among kidney transplant recipients: a meta-analysis[J]. Med Sci, 2020, 8(3): 39. DOI: 10.3390/medsci8030039.
    [53] GIOCO R, CORONA D, EKSER B, et al. Gastrointestinal complications after kidney transplantation[J]. World J Gastroenterol, 2020, 26(38): 5797-5811. DOI: 10.3748/wjg.v26.i38.5797.
    [54] VERDONK RC, DIJKSTRA G, HAAGSMA EB, et al. Inflammatory bowel disease after liver transplantation: risk factors for recurrence and de novo disease[J]. Am J Transplant, 2006, 6(6): 1422-1429. DOI: 10.1111/j.1600-6143.2006.01333.x.
    [55] NANNEGARI V, ROQUE S, RUBIN DT, et al. A review of inflammatory bowel disease in the setting of liver transplantation[J]. Gastroenterol Hepatol (N Y), 2014, 10(10): 626-630.
    [56] PARAMESWARAN S, SINGH K, NADA R, et al. Ulcerative colitis after renal transplantation: a case report and review of literature[J]. Indian J Nephrol, 2011, 21(2): 120-122. DOI: 10.4103/0971-4065.78063.
    [57] RILEY TR, SCHOEN RE, LEE RG, et al. A case series of transplant recipients who despite immunosuppression developed inflammatory bowel disease[J]. Am J Gastroenterol, 1997, 92(2): 279-282.
    [58] ANANTHAKRISHNAN AN. Epidemiology and risk factors for IBD[J]. Nat Rev Gastroenterol Hepatol, 2015, 12(4): 205-217. DOI: 10.1038/nrgastro.2015.34.
    [59] SINGH N, BERNSTEIN CN. Environmental risk factors for inflammatory bowel disease[J]. United European Gastroenterol J, 2022, 10(10): 1047-1053. DOI: 10.1002/ueg2.12319.
    [60] OWCZAREK D, RODACKI T, DOMAGAŁA-RODACKA R, et al. Diet and nutritional factors in inflammatory bowel diseases[J]. World J Gastroenterol, 2016, 22(3): 895-905. DOI: 10.3748/wjg.v22.i3.895.
    [61] TAN T, LAWRANCE IC. Use of mycophenolate mofetil in inflammatory bowel disease[J]. World J Gastroenterol, 2009, 15(13): 1594-1599. DOI: 10.3748/wjg.15.1594.
    [62] INDRIOLO A, RAVELLI P. Clinical management of inflammatory bowel disease in the organ recipient[J]. World J Gastroenterol, 2014, 20(13): 3525-3533. DOI: 10.3748/wjg.v20.i13.3525.
    [63] HALIM MA, SAID T, NAIR P, et al. De novo Crohn’s disease in a renal transplant recipient[J]. Transplant Proc, 2007, 39(4): 1278-1279. DOI: 10.1016/j.transproceed.2007.03.045.
    [64] JØRGENSEN KK, LINDSTRÖM L, CVANCAROVA M, et al. Immunosuppression after liver transplantation for primary sclerosing cholangitis influences activity of inflammatory bowel disease[J]. Clin Gastroenterol Hepatol, 2013, 11(5): 517-523. DOI: 10.1016/j.cgh.2012.12.027.
    [65] DVORCHIK I, SUBOTIN M, DEMETRIS AJ, et al. Effect of liver transplantation on inflammatory bowel disease in patients with primary sclerosing cholangitis[J]. Hepatology, 2002, 35(2): 380-384. DOI: 10.1053/jhep.2002.30695.
    [66] SAKAMOTO T, SATO Y, YAMAMOTO S, et al. De novo ulcerative colitis and autoimmune hepatitis after living related liver transplantation from cytomegalovirus-positive donor to cytomegalovirus-negative recipient: a case report[J]. Transplant Proc, 2012, 44(2): 570-573. DOI: 10.1016/j.transproceed.2012.01.007.
    [67] NEPAL S, NAVANEETHAN U, BENNETT AE, et al. De novo inflammatory bowel disease and its mimics after organ transplantation[J]. Inflamm Bowel Dis, 2013, 19(7): 1518-1527. DOI: 10.1097/MIB.0b013e318 2813365.
    [68] IMBRIZI M, MAGRO F, COY CSR. Pharmacological therapy in inflammatory bowel diseases: a narrative review of the past 90 years[J]. Pharmaceuticals(Basel), 2023, 16(9): 1272.
    [69] HAAGSMA EB, VAN DEN BERG AP, KLEIBEUKER JH, et al. Inflammatory bowel disease after liver transplantation: the effect of different immunosuppressive regimens[J]. Aliment Pharmacol Ther, 2003, 18(1): 33-44. DOI: 10.1046/j.1365-2036.2003.01613.x.
    [70] OKI R, HIDAKA S, SASAKI A, et al. De novo ulcerative colitis after kidney transplantation treated with infliximab[J]. CEN Case Rep, 2021, 10(4): 500-505. DOI: 10.1007/s13730-021-00599-6.
    [71] KOJIMA K, TAKADA J, KAMEI M, et al. Steroid refractory severe ulcerative colitis after kidney transplantation successfully treated with infliximab[J]. Clin J Gastroenterol, 2023, 16(6): 848-853. DOI: 10.1007/s12328-023-01857-z.
    [72] CRESCI GA, BAWDEN E. Gut microbiome: what we do and don't know[J]. Nutr Clin Pract., 2015, 30(6): 734-746. DOI: 10.1177/0884533615609899.
    [73] 中华预防医学会微生态学分会. 中国微生态调节剂临床应用专家共识(2020版)[J]. 中国微生态学杂志, 2020, 32(8): 953-965. DOI: 10.13381/j.cnki.cjm.2020 08020.

    Branch of Microecology of Chinese Preventive Medicine Association. Chinese expert consensus on clinical application of microecological agents (2020 version)[J]. Chin J Microecol, 2020, 32(8): 953-965. DOI: 10.13381/j.cnki.cjm.202008020.
    [74] RICHARD ML, SOKOL H. The gut mycobiota: insights into analysis, environmental interactions and role in gastrointestinal diseases[J]. Nat Rev Gastroenterol Hepatol, 2019, 16(6): 331-345. DOI: 10.1038/s41575-019-0121-2.
    [75] CARDING S, VERBEKE K, VIPOND DT, et al. Dysbiosis of the gut microbiota in disease[J]. Microb Ecol Health Dis, 2015, 26: 26191. DOI: 10.3402/mehd.v26.26191.
    [76] YE J, YAO J, HE F, et al. Regulation of gut microbiota: a novel pretreatment for complications in patients who have undergone kidney transplantation[J]. Front Cell Infect Microbiol, 2023, 13: 1169500. DOI: 10.3389/fcimb.2023.1169500.
    [77] LEE JR, MUTHUKUMAR T, DADHANIA D, et al. Gut microbial community structure and complications after kidney transplantation: a pilot study[J]. Transplantation, 2014, 98(7): 697-705. DOI: 10.1097/TP.00000000 00000370.
    [78] CRESPO-SALGADO J, VEHASKARI VM, STEWART T, et al. Intestinal microbiota in pediatric patients with end stage renal disease: a Midwest Pediatric Nephrology Consortium study[J]. Microbiome, 2016, 4(1): 50. DOI: 10.1186/s40168-016-0195-9.
    [79] KIM JE, KIM HE, CHO H, et al. Effect of the similarity of gut microbiota composition between donor and recipient on graft function after living donor kidney transplantation[J]. Sci Rep, 2020, 10(1): 18881. DOI: 10.1038/s41598-020-76072-8.
    [80] GABARRE P, LOENS C, TAMZALI Y, et al. Immunosuppressive therapy after solid organ transplantation and the gut microbiota: Bidirectional interactions with clinical consequences[J]. Am J Transplant, 2022, 22(4): 1014-1030. DOI: 10.1111/ajt.16836.
    [81] MODI SR, COLLINS JJ, RELMAN DA. Antibiotics and the gut microbiota[J]. J Clin Invest, 2014, 124(10): 4212-4218. DOI: 10.1172/JCI72333.
    [82] SERBANESCU MA, MATHENA RP, XU J, et al. General anesthesia alters the diversity and composition of the intestinal microbiota in mice[J]. Anesth Analg, 2019, 129(4): e126-e129. DOI: 10.1213/ANE.0000000000003938.
    [83] CONLON MA, BIRD AR. The impact of diet and lifestyle on gut microbiota and human health[J]. Nutrients, 2014, 7(1): 17-44. DOI: 10.3390/nu7010017.
    [84] PANDEY KR, NAIK SR, VAKIL BV. Probiotics, prebiotics and synbiotics- a review[J]. J Food Sci Technol, 2015, 52(12): 7577-7587. DOI: 10.1007/s13197-015-1921-1.
    [85] GUARNER F, KHAN AG, GARISCH J, et al. World Gastroenterology Organisation Global Guidelines: probiotics and prebiotics October 2011[J]. J Clin Gastroenterol, 2012, 46(6): 468-481. DOI: 10.1097/MCG.0b013e3182549092.
    [86] 国家卫生健康委员会医院管理研究所, 中华医学会肠外肠内营养学分会, 中华医学会肠外肠内营养学分会肠道微生态协作组. 肠道菌群移植临床应用管理中国专家共识(2022版)[J]. 中华胃肠外科杂志, 2022, 25(9): 747-756. DOI: 10.3760/cma.j.cn441530-202207 25-00324.

    Hospital Management Research Institute of the National Health Commission, Extracorporeal and Enteral Nutrition Branch of the Chinese Medical Association, Intestinal Microecology Collaborative Group of Branch of Extracorporeal and Enteral Nutrition of Chinese Medical Association. Expert consensus on clinical application management of fecal microbiota transplantation (2022 edition)[J]. Chin J Gastrointest Surg, 2022, 25(9): 747-756. DOI: 10.3760/cma.j.cn441530-20220725-00324.
    [87] VALDES AM, WALTER J, SEGAL E, et al. Role of the gut microbiota in nutrition and health[J]. BMJ, 2018, 361: k2179. DOI: 10.1136/bmj.k2179.
    [88] IANIRO G, ROSSI E, THOMAS AM, et al. Faecal microbiota transplantation for the treatment of diarrhoea induced by tyrosine-kinase inhibitors in patients with metastatic renal cell carcinoma[J]. Nat Commun, 2020, 11(1): 4333. DOI: 10.1038/s41467-020-18127-y.
    [89] RANGANATHAN N, RANGANATHAN P, FRIEDMAN EA, et al. Pilot study of probiotic dietary supplementation for promoting healthy kidney function in patients with chronic kidney disease[J]. Adv Ther, 2010, 27(9): 634-647. DOI: 10.1007/s12325-010-0059-9.
    [90] CHAN S, HAWLEY CM, PASCOE EM, et al. Prebiotic supplementation in kidney transplant recipients for preventing infections and gastrointestinal upset: a randomized controlled feasibility study[J]. J Ren Nutr, 2022, 32(6): 718-725. DOI: 10.1053/j.jrn.2022.02.006.
    [91] GUIDA B, CATALDI M, MEMOLI A, et al. Effect of a short-course treatment with synbiotics on plasma p-cresol concentration in kidney transplant recipients[J]. J Am Coll Nutr, 2017, 36(7): 586-591. DOI: 10.1080/07315724.2017.1334602.
    [92] SAWAS T, AL HALABI S, HERNAEZ R, et al. Patients receiving prebiotics and probiotics before liver transplantation develop fewer infections than controls: a systematic review and meta-analysis[J]. Clin Gastroenterol Hepatol, 2015, 13(9): 1567-1574. e3. DOI: 10.1016/j.cgh.2015.05.027.
    [93] BIEHL LM, CRUZ AGUILAR R, FAROWSKI F, et al. Fecal microbiota transplantation in a kidney transplant recipient with recurrent urinary tract infection[J]. Infection, 2018, 46(6): 871-874. DOI: 10.1007/s15010-018-1190-9.
    [94] LIN SC, ALONSO CD, MOSS AC. Fecal microbiota transplantation for recurrent Clostridium difficile infection in patients with solid organ transplants: an institutional experience and review of the literature[J]. Transpl Infect Dis, 2018, 20(6): e12967. DOI: 10.1111/tid.12967.
    [95] GU B, BO GZ, KE C. Exploration of fecal microbiota transplantation in the treatment of refractory diarrhea after renal transplantation[J]. Transplant Proc, 2018, 50(5): 1326-1331. DOI: 10.1016/j.transproceed.2018.03.013.
  • 加载中
表(1)
计量
  • 文章访问数:  33
  • HTML全文浏览量:  17
  • PDF下载量:  15
  • 被引次数: 0
出版历程
  • 收稿日期:  2024-04-18
  • 网络出版日期:  2024-05-16

目录

    /

    返回文章
    返回